Lineage Cell Therapeutics (LCTX) Net Margin (2010 - 2026)
Lineage Cell Therapeutics' Net Margin came in at 138.63% for Q2 2026, up 1240.41 percentage points from -1101.77% a year earlier and up 552.32 percentage points from the prior quarter.
Lineage Cell Therapeutics (LCTX) Net Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lineage Cell Therapeutics reported Net Margin of -264.34%, up 110.50 percentage points year-over-year; for FY2025, it came in at -436.47%, down 240.57 percentage points from FY2024.
- Net Margin carries a five-year change of +694.36 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -195.90% in FY2024 (+44.30 pp), -240.20% in FY2023 (-61.51 pp), -178.69% in FY2022 (+812.30 pp) and -990.99% in FY2021 (+139.84 pp).
- The Q2 2026 figure represents the highest quarterly Net Margin since Q4 2020.
- Year-over-year, Net Margin increased in five of the last eight quarters, with an average year-over-year change of +73.78 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q4 2022 (a gain of 2150.39 percentage points), and the weakest in Q4 2021 (a drop of 3054.59 percentage points).
- Business Quant data shows LCTX's Net Margin at -413.68% (Q1 2026), 12.88% (Q4 2025) and -809.05% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 138.63% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 138.63% |
| Mar 31, 2026 | -413.68% |
| Dec 31, 2025 | 12.88% |
| Sep 30, 2025 | -809.05% |
| Jun 30, 2025 | -1,101.77% |
| Mar 31, 2025 | -275.57% |
| Dec 31, 2024 | -114.12% |
| Sep 30, 2024 | -80.29% |
| Jun 30, 2024 | -409.09% |
| Mar 31, 2024 | -453.05% |
| Dec 31, 2023 | -228.69% |
| Sep 30, 2023 | -570.63% |
| Jun 30, 2023 | -162.14% |
| Mar 31, 2023 | -183.24% |
| Dec 31, 2022 | -331.80% |
| Sep 30, 2022 | -202.43% |
| Jun 30, 2022 | -148.54% |
| Mar 31, 2022 | -135.33% |
| Dec 31, 2021 | -2,482.19% |
| Sep 30, 2021 | -344.63% |
Lineage Cell Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();